5-bromo-2-ethoxyisonicotinic acid – (1379305-67-5)

3'-Sialyllactose, 35890-38-1, Sialyllactose, N-acetylneuraminoyllactose, 3'-Monosialyllactose, (2S, 4S, 5R, 6R)-5-acetamido-2-[(2R, 3S, 4S, 5R, 6S)-3, 5-dihydroxy-2-(hydroxymethyl)-6-[(2R, 3R, 4R, 5R)-1, 2, 4, 5-tetrahydroxy-6-oxohexan-3-yl]oxyoxan-4-yl]oxy-4-hydroxy-6-[(1R, 2R)-1, 2, 3-trihydroxypropyl]oxane-2-carboxylic acid, 3'-a-Sialyllactose, a2, 3-Sialyllactose, 3'-Sialyl-D-lactose, (2>3')-a-Sialyllactose, 3J7TAL60G3, 32-N-Acetyl-a-neuraminyllactose, 3'-N-Acetylneuraminyl-D-lactose, 3'-(N-Acetyl-a-neuraminosyl)lactose, 3'-Sialyllactose Sodium Salt, a-Neu5Ac-(2>3)-b-D-Gal-(1>4)-D-Glc, D-Glucose, O-(N-acetyl-.alpha.-neuraminosyl)-(2.fwdarw.3)-O-.beta.-D-galactopyranosyl-(1.fwdarw.4)-, UNII-3J7TAL60G3, 3a(2)-Sialyllactose, NAN-LACTOSE, GM3 Ganglioside sugar, NEURAMIN LACTOSE, CYLAC 23, (2>3')-alpha-Sialyllactose, SCHEMBL8673965, DTXSID30905216, OIZGSVFYNBZVIK-FHHHURIISA-N, 3'-SL, .ALPHA.-2, 3-SIALYLLACTOSE, AKOS015916417, OS04397, AS-82746, 3'-N-Acetylneuraminyl-D-lactose sodium slt, HY-108065, CS-0027263, NS00124068, 32-N-ACETYL-.ALPHA.-NEURAMINYLLACTOSE, 3'-(N-ACETYL-.ALPHA.-NEURAMINOSYL)LACTOSE, alpha-Neu5Ac-(2>3)-beta-D-Gal-(1>4)-D-Glc, Q3482888, alpha-Neu5Ac-(2>3)-beta-delta-Gal-(1>4)-delta-Glc, N-ACETYL-.ALPHA.-NEURAMINYL-(2 TO 3')-LACTOSE, D-Glucose, O-(N-acetyl-a-neuraminosyl)-(2>3)-O-b-D-galactopyranosyl-(1>4)- (9CI), D-Glucose, O-(N-acetyl-alpha-neuraminosyl)-(2->3)-O-beta-D-galactopyranosyl-(1->4)-, 18409-13-7, D-GLUCOSE, O-(N-ACETYL-.ALPHA.-NEURAMINOSYL)-(2 TO 3)-O-.BETA.-D-GALACTOPYRANOSYL-(1 TO 4)-, D-Glucose, O-(N-acetyl-alpha-neuraminosyl)-(2.fwdarw.3)-O-beta-D-galactopyranosyl-(1.fwdarw.4)-, D-glucose, O-5-(acetylamino)-3, 5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranonosyl-(2>3)-O-b-D-galactopyranosyl-(1>4)-, Neu5Ac-a-2-3-Gal-b-1-4-Glc GM3 trisaccharide sodium salt 3'-N-Acetylneuraminyl-D-lactose sodium slt NANA-Lactose 3'-SL